13.70
price up icon2.32%   0.31
after-market アフターアワーズ: 13.89 0.19 +1.39%
loading
前日終値:
$13.39
開ける:
$13.34
24時間の取引高:
3.32M
Relative Volume:
1.22
時価総額:
$1.18B
収益:
$139.71M
当期純損益:
$-209.36M
株価収益率:
-4.6284
EPS:
-2.96
ネットキャッシュフロー:
$-160.60M
1週間 パフォーマンス:
+1.26%
1か月 パフォーマンス:
-10.95%
6か月 パフォーマンス:
-3.18%
1年 パフォーマンス:
-27.36%
1日の値動き範囲:
Value
$13.30
$14.06
1週間の範囲:
Value
$12.99
$14.06
52週間の値動き範囲:
Value
$8.58
$22.50

Syndax Pharmaceuticals Inc Stock (SNDX) Company Profile

Name
名前
Syndax Pharmaceuticals Inc
Name
セクター
Healthcare (1135)
Name
電話
781-419-1400
Name
住所
730 THIRD AVENUE, NEW YORK, MA
Name
職員
184
Name
Twitter
@syndax
Name
次回の収益日
2025-03-03
Name
最新のSEC提出書
Name
SNDX's Discussions on Twitter

SNDX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
SNDX
Syndax Pharmaceuticals Inc
13.70 1.15B 139.71M -209.36M -160.60M -2.96
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
425.57 107.66B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
651.80 68.74B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.04 58.93B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
818.50 50.51B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
189.60 41.29B 447.02M -1.18B -868.57M -6.1812

Syndax Pharmaceuticals Inc Stock (SNDX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-10-16 再開されました H.C. Wainwright Buy
2025-09-10 再開されました Stifel Buy
2025-09-04 再開されました Guggenheim Buy
2025-08-05 繰り返されました BTIG Research Buy
2025-07-10 開始されました Goldman Buy
2024-10-24 開始されました UBS Buy
2024-06-28 開始されました Jefferies Buy
2024-01-31 ダウングレード Scotiabank Sector Outperform → Sector Perform
2023-12-22 開始されました Mizuho Buy
2023-10-25 開始されました BofA Securities Buy
2023-10-11 開始されました Goldman Buy
2023-07-27 開始されました Scotiabank Sector Outperform
2023-07-11 開始されました Guggenheim Buy
2023-04-17 再開されました BTIG Research Buy
2023-01-31 開始されました Stifel Buy
2023-01-03 開始されました JP Morgan Overweight
2022-07-28 再開されました B. Riley Securities Buy
2022-04-11 開始されました H.C. Wainwright Buy
2022-02-15 開始されました Goldman Buy
2021-06-04 再開されました Robert W. Baird Outperform
2021-05-25 開始されました Citigroup Buy
2021-02-18 開始されました B. Riley Securities Buy
2020-12-03 開始されました Stifel Buy
2020-05-22 アップグレード Citigroup Neutral → Buy
2020-05-22 ダウングレード H.C. Wainwright Buy → Neutral
2020-05-18 ダウングレード Citigroup Buy → Neutral
2020-05-11 繰り返されました H.C. Wainwright Buy
2020-03-04 開始されました Barclays Overweight
2020-01-13 繰り返されました H.C. Wainwright Buy
2019-03-08 繰り返されました H.C. Wainwright Buy
2019-01-04 開始されました Robert W. Baird Outperform
2018-01-05 開始されました B. Riley FBR, Inc. Buy
2017-03-16 開始されました FBR & Co. Outperform
2017-03-02 開始されました Instinet Buy
2016-10-07 開始されました Guggenheim Buy
2016-03-28 開始されました Citigroup Buy
2016-03-28 開始されました JMP Securities Mkt Outperform
2016-03-28 開始されました Morgan Stanley Overweight
すべてを表示

Syndax Pharmaceuticals Inc (SNDX) 最新ニュース

pulisher
Nov 02, 2025

Syndax Pharmaceuticals (SNDX) Q3 Earnings Preview: Key Expectati - GuruFocus

Nov 02, 2025
pulisher
Nov 02, 2025

Kura Oncology's Ziftomenib Poised For Differentiation (NASDAQ:KURA) - Seeking Alpha

Nov 02, 2025
pulisher
Nov 02, 2025

Is Syndax Pharmaceuticals Inc. stock reversal real or fake2025 Risk Factors & Daily Stock Trend Watchlist - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

How risky is Syndax Pharmaceuticals Inc. stock nowJuly 2025 Recap & Free Technical Pattern Based Buy Signals - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Applying Wyckoff theory to Syndax Pharmaceuticals Inc. stockTrade Volume Summary & Verified Technical Trade Signals - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Using Ichimoku Cloud for Syndax Pharmaceuticals Inc. technicalsJuly 2025 Outlook & Scalable Portfolio Growth Methods - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Is Syndax Pharmaceuticals Inc. stock poised for growthJuly 2025 Reactions & Short-Term High Return Strategies - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Y Intercept Hong Kong Ltd Makes New Investment in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat

Nov 01, 2025
pulisher
Oct 31, 2025

B. Riley Issues Optimistic Estimate for SNDX Earnings - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Syndax Pharmaceuticals Inc (SNDX) Q3 2025 Earnings Report Preview: What To Expect - Yahoo Finance

Oct 31, 2025
pulisher
Oct 31, 2025

Syndax Pharmaceuticals Inc (SNDX) Q3 2025 Earnings Report Previe - GuruFocus

Oct 31, 2025
pulisher
Oct 31, 2025

Is it too late to sell Syndax Pharmaceuticals Inc.Weekly Investment Report & Expert Curated Trade Ideas - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Syndax Pharmaceuticals Hits Day Low at $13.03 Amid Price Pressure - Markets Mojo

Oct 31, 2025
pulisher
Oct 31, 2025

Detecting support and resistance levels for Syndax Pharmaceuticals Inc.Earnings Risk Report & Real-Time Volume Spike Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Syndax Pharmaceuticals’ Promising AML Study Update: Key Insights for Investors - TipRanks

Oct 31, 2025
pulisher
Oct 31, 2025

Is Syndax Pharmaceuticals Inc. (1T3) stock considered safe havenJuly 2025 Sentiment & Fast Moving Stock Watchlists - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Why Syndax Pharmaceuticals Inc. stock is rated strong buyJuly 2025 Selloffs & Weekly Momentum Picks - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is Syndax Pharmaceuticals Inc. showing signs of accumulationJuly 2025 Momentum & Stepwise Entry/Exit Trade Alerts - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Published on: 2025-10-30 09:56:20 - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Syndax Pharmaceuticals Launches Promising Phase 3 AML Study with Revumenib - MSN

Oct 30, 2025
pulisher
Oct 30, 2025

Syndax Announces Participation in November Investor Conferences - The Manila Times

Oct 30, 2025
pulisher
Oct 30, 2025

Is Syndax Pharmaceuticals Inc. (1T3) stock a buy during volatile marketsEarnings Risk Summary & Smart Investment Allocation Insights - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Syndax (Nasdaq: SNDX) to join fireside chats at UBS, Guggenheim, Stifel, Jefferies - Stock Titan

Oct 30, 2025
pulisher
Oct 29, 2025

Syndax Pharmaceuticals (SNDX) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

Is Syndax Pharmaceuticals Inc. stock a safe investment in uncertain marketsDividend Hike & AI Driven Stock Price Forecasts - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Leading vs lagging indicators on Syndax Pharmaceuticals Inc. performanceTrend Reversal & Risk Adjusted Buy/Sell Alerts - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Will Syndax Pharmaceuticals Inc. stock maintain momentum in 20252025 Bull vs Bear & AI Powered Buy and Sell Recommendations - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

How Syndax Pharmaceuticals Inc. stock performs in stagflationTrade Risk Report & Risk Adjusted Buy and Sell Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Published on: 2025-10-27 23:41:18 - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

Is Syndax Pharmaceuticals Inc. stock positioned for long term growthJuly 2025 Chart Watch & Fast Gaining Stock Reports - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Will Syndax Pharmaceuticals Inc. stock benefit from sector rotation2025 Top Gainers & Precise Buy Zone Identification - Fundação Cultural do Pará

Oct 27, 2025

Syndax Pharmaceuticals Inc (SNDX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$37.54
price up icon 1.62%
$93.48
price up icon 0.96%
$28.61
price down icon 0.21%
$103.91
price down icon 0.73%
biotechnology ONC
$310.48
price up icon 0.73%
$189.60
price down icon 2.38%
大文字化:     |  ボリューム (24 時間):